-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A666732 | Anti-LAG-3 & PD-1 Reference Antibody (Emb-02), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:Fab-IgG Anti-LAG-3 & PD-1 Reference Antibody (Emb-02), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:Fab-IgG |
|||
| A666733 | Anti-LAG-3 & PD-1 Reference Antibody (Tebotelimab), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:DART-DART-Fc Anti-LAG-3 & PD-1 Reference Antibody (Tebotelimab), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:DART-DART-Fc |
|||
| A666749 | Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:IgG-like Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:IgG-like |
|||
| A998923 | Anti-LAG3 / CD223 Reference Antibody (encelimab), Anti-LAG3 / CD223 Reference Antibody (encelimab), |
|||
| A998924 | Anti-LAG3 / CD223 Reference Antibody (favezelimab), Anti-LAG3 / CD223 Reference Antibody (favezelimab), |
|||
| A998925 | Anti-LAG3 / CD223 Reference Antibody (fianlimab), Anti-LAG3 / CD223 Reference Antibody (fianlimab), |
|||
| A998926 | Anti-LAG3 / CD223 Reference Antibody (ieramilimab), Anti-LAG3 / CD223 Reference Antibody (ieramilimab), |
|||
| A998927 | Anti-LAG3 / CD223 Reference Antibody (miptenalimab), Anti-LAG3 / CD223 Reference Antibody (miptenalimab), |
|||
| A998928 | Anti-LAG3 / CD223 Reference Antibody (relatlimab), Anti-LAG3 / CD223 Reference Antibody (relatlimab), |
|||
| A998930 | Anti-LAP Reference Antibody (Brigham and Womens anti-LAP), Anti-LAP Reference Antibody (Brigham and Womens anti-LAP), |
|||
| A998931 | Anti-LEPR / CD295 Reference Antibody (mibavademab), Anti-LEPR / CD295 Reference Antibody (mibavademab), |
|||
| A998932 | Anti-Lewis Y Reference Antibody (MB 311), Anti-Lewis Y Reference Antibody (MB 311), |
|||
| A998933 | Anti-LIF Reference Antibody (MSC-1), Anti-LIF Reference Antibody (MSC-1), |
|||
| A666752 | Anti-LILRB2 & LILRB4 Reference Antibody (Ngm707), Target:LILRB2&LILRB4,Uniprot:Q8N423&Q8NHJ6,Species:Human,isotype:IgG-like Anti-LILRB2 & LILRB4 Reference Antibody (Ngm707), Target:LILRB2&LILRB4,Uniprot:Q8N423&Q8NHJ6,Species:Human,isotype:IgG-like |
|||
| A998934 | Anti-LILRB2 / ILT4 / CD85d Reference Antibody (JTX-8064), Anti-LILRB2 / ILT4 / CD85d Reference Antibody (JTX-8064), |
|||
| A998935 | Anti-LILRB4 / ILT3 / CD85k Reference Antibody (Merck patent anti-ILT3 complex), Anti-LILRB4 / ILT3 / CD85k Reference Antibody (Merck patent anti-ILT3 complex), |
|||
| A998936 | Anti-LILRB4 / ILT3 / CD85k Reference Antibody (U.Texas patent anti-LILRB4), Anti-LILRB4 / ILT3 / CD85k Reference Antibody (U.Texas patent anti-LILRB4), |
|||
| A998937 | Anti-LINGO1 Reference Antibody (opicinumab), Anti-LINGO1 Reference Antibody (opicinumab), |
|||
| A998938 | Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb), Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb), |
|||
| A998939 | Anti-LOXL2 Reference Antibody (simtuzumab), Anti-LOXL2 Reference Antibody (simtuzumab), |
